List of Tables
Table 1. Global Humira Biosimilar Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Humira Biosimilar Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Humira Biosimilar Market Competitive Situation by Manufacturers in 2022
Table 4. Global Humira Biosimilar Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Humira Biosimilar Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Humira Biosimilar Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Humira Biosimilar Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Humira Biosimilar Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Humira Biosimilar, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Humira Biosimilar, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Humira Biosimilar, Product Type & Application
Table 12. Global Key Manufacturers of Humira Biosimilar, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Humira Biosimilar by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Humira Biosimilar as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Humira Biosimilar Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Humira Biosimilar Sales by Region (2018-2023) & (K Units)
Table 18. Global Humira Biosimilar Sales Market Share by Region (2018-2023)
Table 19. Global Humira Biosimilar Sales by Region (2024-2029) & (K Units)
Table 20. Global Humira Biosimilar Sales Market Share by Region (2024-2029)
Table 21. Global Humira Biosimilar Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Humira Biosimilar Revenue Market Share by Region (2018-2023)
Table 23. Global Humira Biosimilar Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Humira Biosimilar Revenue Market Share by Region (2024-2029)
Table 25. North America Humira Biosimilar Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Humira Biosimilar Sales by Country (2018-2023) & (K Units)
Table 27. North America Humira Biosimilar Sales by Country (2024-2029) & (K Units)
Table 28. North America Humira Biosimilar Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Humira Biosimilar Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Humira Biosimilar Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Humira Biosimilar Sales by Country (2018-2023) & (K Units)
Table 32. Europe Humira Biosimilar Sales by Country (2024-2029) & (K Units)
Table 33. Europe Humira Biosimilar Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Humira Biosimilar Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Humira Biosimilar Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Humira Biosimilar Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Humira Biosimilar Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Humira Biosimilar Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Humira Biosimilar Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Humira Biosimilar Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Humira Biosimilar Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Humira Biosimilar Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Humira Biosimilar Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Humira Biosimilar Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Humira Biosimilar Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Humira Biosimilar Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Humira Biosimilar Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Humira Biosimilar Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Humira Biosimilar Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Humira Biosimilar Sales (K Units) by Type (2018-2023)
Table 51. Global Humira Biosimilar Sales (K Units) by Type (2024-2029)
Table 52. Global Humira Biosimilar Sales Market Share by Type (2018-2023)
Table 53. Global Humira Biosimilar Sales Market Share by Type (2024-2029)
Table 54. Global Humira Biosimilar Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Humira Biosimilar Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Humira Biosimilar Revenue Market Share by Type (2018-2023)
Table 57. Global Humira Biosimilar Revenue Market Share by Type (2024-2029)
Table 58. Global Humira Biosimilar Price (US$/Unit) by Type (2018-2023)
Table 59. Global Humira Biosimilar Price (US$/Unit) by Type (2024-2029)
Table 60. Global Humira Biosimilar Sales (K Units) by Application (2018-2023)
Table 61. Global Humira Biosimilar Sales (K Units) by Application (2024-2029)
Table 62. Global Humira Biosimilar Sales Market Share by Application (2018-2023)
Table 63. Global Humira Biosimilar Sales Market Share by Application (2024-2029)
Table 64. Global Humira Biosimilar Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Humira Biosimilar Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Humira Biosimilar Revenue Market Share by Application (2018-2023)
Table 67. Global Humira Biosimilar Revenue Market Share by Application (2024-2029)
Table 68. Global Humira Biosimilar Price (US$/Unit) by Application (2018-2023)
Table 69. Global Humira Biosimilar Price (US$/Unit) by Application (2024-2029)
Table 70. Cadila Healthcare Corporation Information
Table 71. Cadila Healthcare Description and Business Overview
Table 72. Cadila Healthcare Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Cadila Healthcare Humira Biosimilar Product
Table 74. Cadila Healthcare Recent Developments/Updates
Table 75. Torrent Pharmaceuticals Corporation Information
Table 76. Torrent Pharmaceuticals Description and Business Overview
Table 77. Torrent Pharmaceuticals Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Torrent Pharmaceuticals Humira Biosimilar Product
Table 79. Torrent Pharmaceuticals Recent Developments/Updates
Table 80. Amgen Corporation Information
Table 81. Amgen Description and Business Overview
Table 82. Amgen Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Amgen Humira Biosimilar Product
Table 84. Amgen Recent Developments/Updates
Table 85. Boehringer Ingelheim Corporation Information
Table 86. Boehringer Ingelheim Description and Business Overview
Table 87. Boehringer Ingelheim Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Boehringer Ingelheim Humira Biosimilar Product
Table 89. Boehringer Ingelheim Recent Developments/Updates
Table 90. Novartis Corporation Information
Table 91. Novartis Description and Business Overview
Table 92. Novartis Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Novartis Humira Biosimilar Product
Table 94. Novartis Recent Developments/Updates
Table 95. Samsung Bioepis Corporation Information
Table 96. Samsung Bioepis Description and Business Overview
Table 97. Samsung Bioepis Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Samsung Bioepis Humira Biosimilar Product
Table 99. Samsung Bioepis Recent Developments/Updates
Table 100. Viatris Corporation Information
Table 101. Viatris Description and Business Overview
Table 102. Viatris Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Viatris Humira Biosimilar Product
Table 104. Viatris Recent Developments/Updates
Table 105. Pfizer Corporation Information
Table 106. Pfizer Description and Business Overview
Table 107. Pfizer Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Pfizer Humira Biosimilar Product
Table 109. Pfizer Recent Developments/Updates
Table 110. Fresenius Kabi Corporation Information
Table 111. Fresenius Kabi Description and Business Overview
Table 112. Fresenius Kabi Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Fresenius Kabi Humira Biosimilar Product
Table 114. Fresenius Kabi Recent Developments/Updates
Table 115. Coherus Corporation Information
Table 116. Coherus Description and Business Overview
Table 117. Coherus Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Coherus Humira Biosimilar Product
Table 119. Coherus Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Humira Biosimilar Distributors List
Table 123. Humira Biosimilar Customers List
Table 124. Humira Biosimilar Market Trends
Table 125. Humira Biosimilar Market Drivers
Table 126. Humira Biosimilar Market Challenges
Table 127. Humira Biosimilar Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Humira Biosimilar
Figure 2. Global Humira Biosimilar Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Humira Biosimilar Market Share by Type in 2022 & 2029
Figure 4. Syringe Product Picture
Figure 5. Pen Product Picture
Figure 6. Global Humira Biosimilar Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Humira Biosimilar Market Share by Application in 2022 & 2029
Figure 8. Ankylosing Spondylitis
Figure 9. Rheumatoid Arthritis
Figure 10. Crohn’s Disease
Figure 11. Other
Figure 12. Global Humira Biosimilar Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Humira Biosimilar Market Size (2018-2029) & (US$ Million)
Figure 14. Global Humira Biosimilar Sales (2018-2029) & (K Units)
Figure 15. Global Humira Biosimilar Average Price (US$/Unit) & (2018-2029)
Figure 16. Humira Biosimilar Report Years Considered
Figure 17. Humira Biosimilar Sales Share by Manufacturers in 2022
Figure 18. Global Humira Biosimilar Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Humira Biosimilar Players: Market Share by Revenue in 2022
Figure 20. Humira Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Humira Biosimilar Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Humira Biosimilar Sales Market Share by Country (2018-2029)
Figure 23. North America Humira Biosimilar Revenue Market Share by Country (2018-2029)
Figure 24. United States Humira Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Humira Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Humira Biosimilar Sales Market Share by Country (2018-2029)
Figure 27. Europe Humira Biosimilar Revenue Market Share by Country (2018-2029)
Figure 28. Germany Humira Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Humira Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Humira Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Humira Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Humira Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Humira Biosimilar Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Humira Biosimilar Revenue Market Share by Region (2018-2029)
Figure 35. China Humira Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Humira Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Humira Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Humira Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Humira Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Humira Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Southeast Asia Humira Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Humira Biosimilar Sales Market Share by Country (2018-2029)
Figure 43. Latin America Humira Biosimilar Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Humira Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Humira Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Humira Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Colombia Humira Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Humira Biosimilar Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Humira Biosimilar Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Humira Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Humira Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Humira Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Humira Biosimilar by Type (2018-2029)
Figure 54. Global Revenue Market Share of Humira Biosimilar by Type (2018-2029)
Figure 55. Global Humira Biosimilar Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Humira Biosimilar by Application (2018-2029)
Figure 57. Global Revenue Market Share of Humira Biosimilar by Application (2018-2029)
Figure 58. Global Humira Biosimilar Price (US$/Unit) by Application (2018-2029)
Figure 59. Humira Biosimilar Value Chain
Figure 60. Humira Biosimilar Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
